Sobha’s Real Estate Sales Dip In Q2
Sobha Ltd.'s sales fell in the quarter ended September even as its price realisation rose.
The Bengaluru-based developer's sales fell by nearly 14% over a year ago to 8.91 lakh square feet. In terms of value, sales dropped by 5.4% to Rs 530.9 crore, it said in an exchange filing on Monday.
Still, average price realisation rose by nearly 17.5% to Rs 7,737 per sq. ft.—the highest in five quarters.
Nearly two-thirds of the company's sales was in Bengaluru. “We continue to perform well in Bengaluru but dependency on Bengaluru sales volume has reduced from 74% during Q1-21 to 60% during Q2-21,” Sobha said in the filing. The company's sales volume in India's IT capital fell by 31% to 5.38 lakh sq. ft.
The company made no new launches during the three-month period—at a time when the country has gradually started easing the restrictions that were imposed following the Covid-19 outbreak. Enquiry levels are now back to almost pre-pandemic levels, it said.
Sobha said it remains focused on cash flow management and cost optimisation. “We continue to bring down our average cost of borrowing and as a result, cost of borrowing as of Sept. 30, 2020, came down meaningfully.”
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.